🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I'll be there too! Come talk to us about your research.

A must read for pediatric oncologists.

A must read if you are heading to the #AACR25 session on CAR-T Cells in Hematological Malignancies: Innovations and Pitfalls from Kai Rejeski Memorial Sloan Kettering Cancer Center. brnw.ch/21wSePV

Just before landing in Chicago, above a sea of fluffy clouds. #AACR25

If you enjoyed the session “Cancer Predisposition in Childhood Cancer: Implications for Prevention, Surveillance, Interception, and Survivorship Care ", then check out the recent series on the topic. #AACR25 brnw.ch/21wSeVa

Opening ceremony begins tomorrow. #AACR25

Repurposing epalrestat in lung cancer. Epalrestat has the potential to advance to clinical trials in patients with drug-resistant NSCLC due to favorable toxicity, pharmacological profile, and bioavailability. #AACR

Congratulations! It was great meeting you last night. #AACR25

#AACR25

If you are attending the Clinical Trial Symposium on Advances in Immunotherapy at #AACR25, then check out this recent Clinical Cancer Research article on the topic by speaker Ravindra Uppaturi. brnw.ch/21wSfNE Brigham and Women’s Department of Surgery

Microbiota plays an important role in cancer development and therapeutic responses. Want more from #AACR25 session The Microbiota and Cancer Prevention, Diagnosis, and Treatment, then check out this paper. brnw.ch/21wSfSR

Attending #AACR25 session on Liquid Biopsy: Circulating Tumor Cells? You might be interested in this recent study. brnw.ch/21wSfTd

And don't miss your chance to meet Dr. Yap today. Meet the new Editor-in-Chief of Clinical Cancer Research, at 2:00 PM on Monday, April 28 at the Publications Booth 2615. brnw.ch/21wSfNU

This is a great collection!

Today is the day!!! Come talk with the EIC of Clinical Cancer Research, Timothy Yap, at the #AACR25 booth #2615 at 2:00. I'll be there too.

That is snazzy!

The cover shows a metastatic lymph node from a patient w/oral squamous cell carcinoma. Multiplex immunohistochemical staining highlights the spatial interplay of PERK+ macrophages, activated fibroblasts & tumor cells in an immunosuppressive niche. Article by Zhang et al Clinical Cancer Research

The first-in-human U.S. phase I results of taletrectinib were published in our journal for patients with solid tumors: aacrjournals.org/clincancerres/…

Phase 3 Study: EGFR-TKI and Intercalated Chemotherapy for EGFR-mutant NSCLC. aacrjournals.org/clincancerres/…

Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced NSCLC. brnw.ch/21wTZdj